We are currently using the FASCIA method for in vitro stimulation of whole blood (ref: Marits P. et al. Clin Immunol PubMed ID 24909732). We use PHA, PWM and ConA for stimulation but I don't really understand where the differences in responses come from with these mitogens. Some times the same donor has a perfect response to PHA but only a moderate response to ConA. Does anyone happen to know why?

We'd like to have a stimulant that would be TCR specific but the CD3-CD28-antibody stimulation does not work in this setting since the incubation time is very long and the cells downregulate CD3 making it impossible to gate on them in flow cytometry analysis. Any recommendations for CD3-CD28 replacement that would still be TCR-specific and give robust responses?

All input is greatly appreciated!

More Eliisa Kekäläinen's questions See All
Similar questions and discussions